Bicycle Therapeutics PLC
NASDAQ:BCYC
Income Statement
Earnings Waterfall
Bicycle Therapeutics PLC
Revenue
|
41.6m
USD
|
Operating Expenses
|
-221.5m
USD
|
Operating Income
|
-179.9m
USD
|
Other Expenses
|
11.7m
USD
|
Net Income
|
-168.2m
USD
|
Income Statement
Bicycle Therapeutics PLC
Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||
Revenue |
7
N/A
|
7
+6%
|
11
+50%
|
11
-1%
|
10
-9%
|
14
+44%
|
9
-38%
|
9
+1%
|
12
+38%
|
10
-12%
|
11
+7%
|
11
+2%
|
12
+4%
|
12
-1%
|
14
+18%
|
16
+19%
|
15
-8%
|
14
-4%
|
16
+7%
|
23
+45%
|
25
+10%
|
27
+9%
|
42
+54%
|
|
Operating Income | ||||||||||||||||||||||||
Operating Expenses |
(27)
|
(29)
|
(33)
|
(36)
|
(39)
|
(40)
|
(43)
|
(48)
|
(51)
|
(63)
|
(67)
|
(72)
|
(77)
|
(78)
|
(91)
|
(103)
|
(117)
|
(131)
|
(146)
|
(170)
|
(192)
|
(216)
|
(221)
|
|
Selling, General & Administrative |
(8)
|
(8)
|
(10)
|
(11)
|
(13)
|
(15)
|
(16)
|
(19)
|
(22)
|
(30)
|
(32)
|
(33)
|
(35)
|
(33)
|
(42)
|
(45)
|
(47)
|
(49)
|
(46)
|
(50)
|
(56)
|
(60)
|
(62)
|
|
Research & Development |
(18)
|
(21)
|
(23)
|
(25)
|
(26)
|
(26)
|
(27)
|
(28)
|
(30)
|
(33)
|
(35)
|
(39)
|
(42)
|
(45)
|
(49)
|
(58)
|
(70)
|
(82)
|
(100)
|
(119)
|
(137)
|
(156)
|
(159)
|
|
Operating Income |
(20)
N/A
|
(22)
-9%
|
(22)
-2%
|
(25)
-14%
|
(29)
-16%
|
(26)
+10%
|
(35)
-32%
|
(39)
-13%
|
(40)
-1%
|
(53)
-32%
|
(56)
-7%
|
(61)
-8%
|
(65)
-6%
|
(66)
-2%
|
(77)
-17%
|
(87)
-12%
|
(102)
-18%
|
(116)
-14%
|
(130)
-12%
|
(147)
-13%
|
(167)
-14%
|
(189)
-13%
|
(180)
+5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
2
|
4
|
5
|
6
|
10
|
13
|
|
Total Other Income |
(0)
|
(1)
|
(4)
|
(6)
|
(6)
|
(5)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(20)
N/A
|
(22)
-12%
|
(26)
-16%
|
(31)
-20%
|
(34)
-12%
|
(31)
+10%
|
(36)
-16%
|
(38)
-6%
|
(39)
-2%
|
(52)
-33%
|
(57)
-10%
|
(63)
-10%
|
(67)
-7%
|
(68)
-2%
|
(80)
-17%
|
(89)
-12%
|
(103)
-15%
|
(114)
-11%
|
(126)
-10%
|
(142)
-13%
|
(161)
-13%
|
(179)
-11%
|
(166)
+7%
|
|
Net Income | ||||||||||||||||||||||||
Tax Provision |
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
(1)
|
(1)
|
(2)
|
|
Income from Continuing Operations |
(20)
|
(22)
|
(26)
|
(31)
|
(34)
|
(31)
|
(35)
|
(37)
|
(38)
|
(51)
|
(56)
|
(62)
|
(66)
|
(67)
|
(78)
|
(87)
|
(101)
|
(113)
|
(124)
|
(140)
|
(162)
|
(181)
|
(168)
|
|
Net Income (Common) |
(20)
N/A
|
(22)
-11%
|
(26)
-18%
|
(31)
-20%
|
(34)
-10%
|
(31)
+10%
|
(35)
-16%
|
(37)
-5%
|
(38)
-2%
|
(51)
-34%
|
(56)
-10%
|
(62)
-10%
|
(66)
-7%
|
(67)
-1%
|
(78)
-17%
|
(87)
-11%
|
(101)
-16%
|
(113)
-12%
|
(124)
-10%
|
(140)
-13%
|
(162)
-15%
|
(181)
-12%
|
(168)
+7%
|
|
EPS (Diluted) |
-1.11
N/A
|
-1.23
-11%
|
-1.46
-19%
|
-1.75
-20%
|
-1.92
-10%
|
-2.77
-44%
|
-1.98
+29%
|
-2.08
-5%
|
-1.95
+6%
|
-2.66
-36%
|
-2.52
+5%
|
-2.56
-2%
|
-2.64
-3%
|
-2.67
-1%
|
-2.64
+1%
|
-2.93
-11%
|
-3.41
-16%
|
-3.8
-11%
|
-4.14
-9%
|
-4.63
-12%
|
-4.08
+12%
|
-5.08
-25%
|
-3.95
+22%
|